Zai Lab Partner Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-3 Trial of KarXT in Schizophrenia
2023年 3月 20日
Read MoreZai Lab Statement on Silicon Valley Bank (“SVB”) and Joint US Federal Agency Announcement
2023年 3月 12日
Read MoreZai Lab Announces Full-Year 2022 Financial Results and Recent Corporate Updates
2023年 3月 01日
Read MoreZai Lab to Present Two New Phase 3 Analyses for Niraparib in Ovarian Cancer at the 2023 ESMO Gynaecological Cancers Congress
2023年 2月 22日
Read MoreZai Lab Announces NDA Acceptance of Sulbactam-Durlobactam (SUL-DUR) for Infections Caused by Acinetobacter baumannii in China by the NMPA
2023年 2月 22日
Read MoreZai Lab to Announce Full-Year Financial Results and Corporate Updates on March 1, 2023
2023年 2月 09日
Read More